Overall Technical outlook

Price Summary

On 2025-09-05, Alembic Pharmaceuticals Limited's stock began at 959.3, peaked at 967.25, bottomed at 943.2, and closed -1.33% lower at 946.5, with a volume of 26963 shares.
The stock reached its highest price of 1247.7 and lowest price of 743.65 over the last 52 weeks.
The price outlook for APLLTD is between 900.0 and 1345.0, with an average expectation of 1067.091, as estimated by 11 analysts.

Technicals

Support and Resistance: The current price is 946.5, with support at 880.55 and resistance at 952.6. This range suggests that the price might move between these levels, with 880.55 offering support and 952.6 capping further gains for Alembic Pharmaceuticals Limited.
APLLTD supportResistance 83778f
Support/Resistance for APLLTD


Aroon: The current state of the AROON is neutral, with no clear trend direction indicated. This lack of directional bias suggests that the market may be in a phase of consolidation or uncertainty.
APLLTD aroon 83778f
Aroon chart for Alembic Pharmaceuticals Limited


Bol. Bands: The BOLL BANDS is currently in a neutral position, offering no clear indication of movement up or down. This suggests that the market may be experiencing a period of equilibrium, with no strong trend in play.
APLLTD bbands 83778f
Bolinger Bands chart for Alembic Pharmaceuticals Limited


Parabolic SAR: The PSAR maintains its bearish stance, setting a strong resistance level that could limit any potential upward movement. This ongoing bearish outlook suggests that the market may continue to face resistance, making it difficult to achieve significant gains for Alembic Pharmaceuticals Limited.
APLLTD psar 83778f
Parabolic Stop and Reverse chart for Alembic Pharmaceuticals Limited


Stochastic: The STOCHASTIC is in a neutral stance, with no clear signals for movement up or down. This neutral position indicates a potential period of consolidation or uncertainty in the market.
APLLTD stoch 83778f
Stochastic chart for Alembic Pharmaceuticals Limited


Tripple Moving Agerage: The current state of the Tripple MOVING AVG is neutral, with no clear trend direction indicated. This lack of directional bias suggests that the market may be in a phase of consolidation or uncertainty.
APLLTD trippleSMA 83778f
Tripple SMA chart for Alembic Pharmaceuticals Limited


When evaluating a company, it is crucial to examine its fundamentals, including its financial statements, management structure, and market position. Additionally, understanding the broader industry trends, competition, and regulatory landscape helps to create a well-rounded view. By assessing both the company's internal factors and the external environment in which it operates, you can extract more valuable insights from its technical performance, such as stock price movements and trading patterns.